Cover Image
市場調查報告書

Argon Pharma S.L.的產品平台分析

Argon Pharma S.L. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 319960
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Argon Pharma S.L.的產品平台分析 Argon Pharma S.L. - Product Pipeline Review - 2014
出版日期: 2014年11月24日 內容資訊: 英文 21 Pages
簡介

Argon Pharma S.L.是總公司設立於西班牙的生物科技企業,正在研發針對腫瘤領域的未滿足需求之治療藥、新給藥技術、改良既有診斷技術之方法等。

本報告提供Argon Pharma S.L.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,並彙整最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Argon Pharma S.L.的基本資料

  • Argon Pharma S.L.概要
  • 主要資訊
  • 企業資料

Argon Pharma S.L.:R&D概要

  • 主要的治療範圍

Argon Pharma S.L.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Argon Pharma S.L.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

Argon Pharma S.L.:藥物簡介

  • APDD-01
  • APDD-04
  • SOM-0777

Argon Pharma S.L.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Argon Pharma S.L.:最新的開發平台資訊

Argon Pharma S.L.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC06512CDB

Summary

Global Markets Direct's, 'Argon Pharma S.L. - Product Pipeline Review - 2014', provides an overview of the Argon Pharma S.L.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Argon Pharma S.L.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Argon Pharma S.L. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Argon Pharma S.L.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Argon Pharma S.L.'s pipeline products

Reasons to buy

  • Evaluate Argon Pharma S.L.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Argon Pharma S.L. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Argon Pharma S.L.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Argon Pharma S.L. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Argon Pharma S.L.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Argon Pharma S.L. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Argon Pharma S.L. Snapshot
    • Argon Pharma S.L. Overview
    • Key Information
    • Key Facts
  • Argon Pharma S.L. - Research and Development Overview
    • Key Therapeutic Areas
  • Argon Pharma S.L. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Argon Pharma S.L. - Pipeline Products Glance
    • Argon Pharma S.L. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Argon Pharma S.L. - Drug Profiles
    • APDD-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APDD-04
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • SOM-0777
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Argon Pharma S.L. - Pipeline Analysis
    • Argon Pharma S.L. - Pipeline Products by Target
    • Argon Pharma S.L. - Pipeline Products by Route of Administration
    • Argon Pharma S.L. - Pipeline Products by Molecule Type
    • Argon Pharma S.L. - Pipeline Products by Mechanism of Action
  • Argon Pharma S.L. - Recent Pipeline Updates
  • Argon Pharma S.L. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Argon Pharma S.L., Key Information
  • Argon Pharma S.L., Key Facts
  • Argon Pharma S.L. - Pipeline by Indication, 2014
  • Argon Pharma S.L. - Pipeline by Stage of Development, 2014
  • Argon Pharma S.L. - Monotherapy Products in Pipeline, 2014
  • Argon Pharma S.L. - Preclinical, 2014
  • Argon Pharma S.L. - Discovery, 2014
  • Argon Pharma S.L. - Pipeline by Target, 2014
  • Argon Pharma S.L. - Pipeline by Route of Administration, 2014
  • Argon Pharma S.L. - Pipeline by Molecule Type, 2014
  • Argon Pharma S.L. - Pipeline Products by Mechanism of Action, 2014
  • Argon Pharma S.L. - Recent Pipeline Updates, 2014

List of Figures

  • Argon Pharma S.L. - Pipeline by Top 10 Indication, 2014
  • Argon Pharma S.L. - Pipeline by Stage of Development, 2014
  • Argon Pharma S.L. - Monotherapy Products in Pipeline, 2014
  • Argon Pharma S.L. - Pipeline by Top 10 Molecule Type, 2014
Back to Top